Through Invitae’s PGx medication optimization tools, clinicians can address barriers to precision medication management and achieve optimal prescribing. Actionable, personalized drug and dose optimization recommendations are based on a combination of genetics and the latest evidence, so healthcare providers can easily design an effective regimen for each individual patient.
*Invitae accepts reimbursement at 100% of the CMS 2020 National Limitation Amount (NLA) for Invitae SARS-CoV-2 Test, (LOINC: 94500-6), which is currently $100.00. Invitae can bill payers for the cost of the test, so consumers do not incur upfront test costs; however, physician fees are separate and charged to the consumers directly by the healthcare provider. If consumers choose not to take advantage of payer options they can pay the self pay price of $100.00.